Ahmed El-morsy - Concepedia

Author

Ahmed El-morsy

Also Known As

AHMED EL-MORSY, Ahmed El-Morsy, Ahmed El-morsy, Ahmed Elmorsy, Ahmed El‐Morsy, Ahmed M. El-Morsy, Ahmed M. El-morsy, Ahmed M. El‐Morsy

Publications

873

Citations

H-Index

Concepts

All Affiliations

Al-Azhar University Iraqi University Heliopolis University Taibah University University of Tabuk

About

Ahmed El-morsy is an author at Al-Azhar University specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	469
2	Natural Sciences	5	5	267
3	Biochemistry	3	3	193
4	Engineering	2	2	31
5	Biomedical Engineering	1	1	18

Ahmed El-morsy

Publications

835

Citations

H-Index

Page 1

	Year	Citations
Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFRWT and EGFRT790M inhibitors and apoptosis inducers Ahmed A. Abdel Gaber, Ashraf H. Bayoumi, Ahmed El-morsy, Bioorganic Chemistry Tumor BiologyMedicinal ChemistryEgfrt790m InhibitorsMedicinePotent Egfrwt	2018	132
Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects Mohamed Alswah, Ashraf H. Bayoumi, Kamal M. El‐Gamal, Molecules	2017	108
Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors Kamal M. El‐Gamal, Ahmed El-morsy, Ahmad M. Saad, Journal of Molecular Structure Medicinal ChemistryNew Quinoline-3-carbonitrile DerivativesBiochemistryMedicineAntimicrobial Evaluation	2018	83
Pharmacophore‐linked pyrazolo[3,4‐<i>d</i>]pyrimidines as EGFR‐TK inhibitors: Synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies Ahmed A. Abdel Gaber, Ahmed El-morsy, Farag F. Sherbiny, Archiv der Pharmazie	2021	71
Second-Generation Phenylthiazole Antibiotics with Enhanced Pharmacokinetic Properties Mohammed A. Seleem, Ahmed Disouky, Haroon Mohammad, Journal of Medicinal Chemistry Bioorganic ChemistryVitro Anti-mrsa PotencyAntimicrobial ChemotherapySecond-generation AnaloguesPharmaceutical Chemistry	2016	60
Synthesis and Evaluation of Some New (1,2,4) Triazolo(4,3‐a)Quinoxalin‐4(5H)‐one Derivatives as AMPA Receptor Antagonists Hamada S. Abulkhair, Salwa Elmeligie, Ashraf H. Bayoumi, Journal of Heterocyclic Chemistry Molecular PharmacologyMedicinal ChemistryDerivative (Chemistry)DerivativesDiversity Oriented Synthesis	2013	50
In vivo‐ and in silico‐driven identification of novel synthetic quinoxalines as anticonvulsants and AMPA inhibitors Hamada S. Abulkhair, Salwa Elmeligie, Adel Ghiaty, Archiv der Pharmazie	2021	44
Design, synthesis, and molecular docking studies of new [1,2,4]triazolo[4,3-a]quinoxaline derivatives as potential A2B receptor antagonists Hany G. Ezzat, Ashraf H. Bayoumi, Farag F. Sherbiny, Molecular Diversity Combinatorial ChemistryMedicinal ChemistryMedicineNatural SciencesPharmacological Agent	2020	41
Synthesis and Biological Evaluation of Some [1,2,4]Triazolo[4,3-<i>a</i>]quinoxaline Derivatives as Novel Anticonvulsant Agents Mohamed Alswah, Adel Ghiaty, Ahmed El-morsy, ISRN Organic Chemistry Medicinal ChemistryPharmaceutical ChemistryDerivative (Chemistry)MedicinePharmacological Agent	2013	36
Antimicrobial screening and pharmacokinetic profiling of novel phenyl-[1,2,4]triazolo[4,3-a]quinoxaline analogues targeting DHFR and E. coli DNA gyrase B Abdelsattar M. Omar, Mohamed Alswah, Hany E. A. Ahmed, Bioorganic Chemistry Antimicrobial ScreeningAntimicrobial Drug DiscoveryPharmacokinetic ProfilingMedicineAntibacterial Agent	2020	34

Page 1